MicroRNA-21是脓毒症多器官保护中局部与远端缺血预处理的必需分子
本研究为实验室研究,使用小鼠肾小管上皮细胞、C57BL/6J野生型小鼠及microRNA-21-/-小鼠。肾缺血预处理通过双侧肾蒂夹闭15分钟诱导,脓毒症通过单次腹腔注射脂多糖20 mg/kg或盲肠结扎穿孔诱导。肾缺血预处理可保护肾脏、心脏、肝脏和肺免受内毒素血症或 polymicrobial 脓毒症所致多器官损伤,机制涉及缺氧诱导因子-1α上调microRNA-21、血清外泌体及远端器官microRNA-21表达增加、凋亡减少和促炎细胞因子产生减少。体内敲低或基因敲除microRNA-21可消除该器官保护效应。作者认为microRNA-21上调可能是脓毒症的潜在治疗方向。
要点
- 小鼠中,双侧肾蒂夹闭15分钟的肾缺血预处理可减轻脂多糖20 mg/kg或盲肠结扎穿孔所致肾脏、心脏、肝脏和肺的多器官损伤。
- 肾缺血预处理后肾脏缺氧诱导因子-1α激活,在转录水平上调microRNA-21,使血清外泌体和远端器官microRNA-21表达增加。
- 体内敲低microRNA-21或microRNA-21基因敲除可消除肾缺血预处理对脓毒症多器官损伤的保护作用。
- 机制上,敲低microRNA-21增加程序性细胞死亡蛋白4表达和核因子-κB活性,降低抗凋亡B细胞淋巴瘤-2表达。
- 作者认为microRNA-21上调可能是脓毒症的潜在治疗方向。
适用人群与场景
- 小鼠肾小管上皮细胞、C57BL/6J野生型小鼠及microRNA-21-/-小鼠(B6.129-Mir21atm1Smoc)。
- 脓毒症模型为单次腹腔注射脂多糖20 mg/kg或盲肠结扎穿孔诱导的小鼠。
处置流程与药物剂量
- 肾缺血预处理:双侧肾蒂夹闭15分钟。
- 脓毒症诱导:单次腹腔注射脂多糖20 mg/kg,或盲肠结扎穿孔。
- 细胞处理:小鼠肾小管上皮细胞给予缺氧(2%氧气)处理。
研究设计与关键结果
- 实验室研究:肾缺血预处理小鼠免受内毒素血症或 polymicrobial 脓毒症所致多器官损伤,包括肾脏、心脏、肝脏和肺。
- 肾缺血预处理诱导肾脏缺氧诱导因子-1α激活,转录水平上调microRNA-21,随后血清外泌体和远端器官microRNA-21表达增加,这些器官凋亡减少、促炎细胞因子产生减少。
- 体内敲低microRNA-21或microRNA-21基因敲除可消除肾缺血预处理赋予的器官保护效应。
- 机制上,敲低microRNA-21增加程序性细胞死亡蛋白4表达和核因子-κB活性,降低抗凋亡B细胞淋巴瘤-2表达。
证据类型、等级与局限
- 证据类型:实验室研究(小鼠细胞及动物实验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为microRNA-21上调可能是脓毒症的潜在治疗方向。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Sepsis, triggered by microbial infection, is a common and life-threatening systemic illness, often leads to impaired function of vital organs. Ischemic preconditioning induced by transient brief episodes of ischemia is a powerful innate mechanism of organ protection. We have reported that a 15-minute renal ischemic preconditioning substantially attenuated subsequent renal ischemia-reperfusion injury. Here, we investigate whether a brief ischemia and reperfusion in kidney can provide protection at local and remote sites against sepsis-induced organ injury, and whether this protection is microRNA-21 dependent.
DESIGN: Laboratory study.
SETTING: University laboratory.
SUBJECTS: Mouse renal tubular epithelial cells, C57BL/6 J wildtype (Animal Center of Fudan University, Shanghai, China) and microRNA-21-/- mice (B6.129-Mir21atm1Smoc, Shanghai Biomodel Organism Science & Technology Development Co. Shanghai, China).
INTERVENTIONS: Mouse renal tubular epithelial cells were treated with hypoxia (2% oxygen). Renal ischemic preconditioning was induced by bilateral renal pedicle clamping for 15 minutes, and sepsis was induced by a single intraperitoneal injection of lipopolysaccharide at a dose of 20 mg/kg or cecal ligation and puncture in mice.
MEASUREMENTS AND MAIN RESULTS: Mice treated with renal ischemic preconditioning were protected from endotoxemia or polymicrobial sepsis-induced multiple organ injury, including kidneys, heart, liver, and lungs. Renal ischemic preconditioning induced activation of hypoxia-inducible factor-1α in kidneys, which up-regulated microRNA-21 at transcriptional level, subsequently, leading to increased expression of microRNA-21 in serum exosomes and remote organs, resulting in decreased apoptosis and reduced proinflammatory cytokines production in these organs. In vivo knockdown of microRNA-21 or genetic deletion of microRNA-21 abrogated the organoprotective effects conferred by renal ischemic preconditioning. Mechanistically, we discovered that knockdown of microRNA-21 increased programmed cell death protein 4 expression and nuclear factor-kappa B activity, decreased expression of anti-apoptotic B-cell lymphoma-2.
CONCLUSION: MicroRNA-21 is required for local and remote ischemic preconditioning in multiple organ protection against sepsis, and up-regulation of miR-21 may be a potential therapy for sepsis.
参考来源
- Jia P, Wu X, Dai Y, et al. MicroRNA-21 Is Required for Local and Remote Ischemic Preconditioning in Multiple Organ Protection Against Sepsis. Crit Care Med. 2017. PMID: 28437377. doi:10.1097/CCM.0000000000002363
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。